Prediction of Tacrolimus Drug Dosing and Metabolism based on CYP3A5 Polymorphism in Indian Renal Transplant Recipients

被引：0
|
作者：
Patel, Mohan [1 ]
Goswami, Jitendra [3 ]
Balwani, Manish [4 ]
Gumber, Manoj [2 ]
机构：
[1] Apollo Hosp, Dept Nephrol & Transplantat, Nasik, India
[2] Apollo Hosp, Dept Nephrol & Transplantat, Ahmadabad, Gujarat, India
[3] Manipal Hosp, Dept Nephrol & Transplantat, Jaipur, Rajasthan, India
[4] Jawaharlal Nehru Med Coll, Dept Nephrol & Transplantat, Sawangi, Wardha, India
来源：
TRANSPLANTATION | 2018年 / 102卷
关键词：
D O I：
10.1097/01.tp.0000542683.60190.23
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
C391.2
引用
收藏
页码：S92 / S92
页数：1
相关论文
共 50 条
  • [41] THE ASSOCIATION OF BODYWEIGHT AND CYP3A5 GENOTYPE WITH TACROLIMUS TROUGH LEVEL IN CHINESE RENAL TRANSPLANT RECIPIENTS
    Tang, Jang-Tao
    Shi, Yun-Ying
    Li, Yi
    Yan, Lin
    Wang, Ting-Li
    Bai, Yang-Juan
    Zou, Yuan-Gao
    Tao, Ye
    Wang, Lan-Lan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 415 - 416
  • [42] Evaluating tacrolimus pharmacokinetic models in adult renal transplant recipients with different CYP3A5 genotypes
    Can Hu
    Wen-jun Yin
    Dai-yang Li
    Jun-jie Ding
    Ling-yun Zhou
    Jiang-lin Wang
    Rong-rong Ma
    Kun Liu
    Ge Zhou
    Xiao-cong Zuo
    European Journal of Clinical Pharmacology, 2018, 74 : 1437 - 1447
  • [43] Value of CYP3A5 Genotyping on Determining Initial Dosages of Tacrolimus for Chinese Renal Transplant Recipients
    Zhang, J.
    Zhang, X.
    Liu, L.
    Tong, W.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3459 - 3464
  • [44] Tacrolimus Population Pharmacokinetics and Multiple CYP3A5 Genotypes in Black and White Renal Transplant Recipients
    Campagne, Olivia
    Mager, Donald E.
    Brazeau, Daniel
    Venuto, Rocco C.
    Tornatore, Kathleen M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (09): : 1184 - 1195
  • [45] TACROLIMUS POPULATION PHARMACOKINETICS AND CYP3A5 GENOTYPES IN AFRICAN AMERICAN AND CAUCASIAN RENAL TRANSPLANT RECIPIENTS
    Campagne, O.
    Mager, D. E.
    Brazeau, D.
    Venuto, R. C.
    Tornatore, K. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S18 - S18
  • [46] Evaluating tacrolimus pharmacokinetic models in adult renal transplant recipients with different CYP3A5 genotypes
    Hu, Can
    Yin, Wen-jun
    Li, Dai-yang
    Ding, Jun-jie
    Zhou, Ling-yun
    Wan, Jiang-lin
    Ma, Rong-rong
    Liu, Kun
    Zhou, Ge
    Zuo, Xiao-cong
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (11) : 1437 - 1447
  • [47] Tacrolimus Dose Requirement Based on the CYP3A5 Genotype in Renal Transplant Patients
    Qu, L.
    Xie, Z.
    Huang, H.
    Jiang, H.
    Chen, J.
    Jiang, H.
    Jiang, H.
    Chen, J.
    Chen, J.
    Chen, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 747 - 747
  • [48] Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
    Qu, Lihui
    Lu, Yingying
    Ying, Meike
    Li, Bingjue
    Weng, Chunhua
    Xie, Zhoutao
    Liang, Ludan
    Lin, Chuan
    Yang, Xian
    Feng, Shi
    Wang, Yucheng
    Shen, Xiujin
    Zhou, Qin
    Chen, Ying
    Chen, Zhimin
    Wu, Jianyong
    Lin, Weiqiang
    Shen, Yi
    Qin, Jing
    Xu, Hang
    Xu, Feng
    Wang, Junwen
    Chen, Jianghua
    Jiang, Hong
    Huang, Hongfeng
    ONCOTARGET, 2017, 8 (46) : 81285 - 81294
  • [49] Interaction between tacrolimus and calcium channel blockers based on CYP3A5 genotype in Chinese renal transplant recipients
    Zong, Huiying
    Zhang, Yundi
    Liu, Fengxi
    Zhang, Xiaoming
    Yang, Yilei
    Cao, Xiaohong
    Li, Yue
    Li, Anan
    Zhou, Penglin
    Gao, Rui
    Li, Yan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [50] ASSOCIATION BETWEEN CYP3A5*3 AND PPARA GENE VARIANTS ON TACROLIMUS CONCENTRATIONS IN RENAL TRANSPLANT RECIPIENTS
    Lunde, Ingrid
    Midtvedt, Karsten
    Mohebi, Beata
    Dahl, Miriam
    Bergan, Stein
    Asberg, Anders
    Christensen, Hege
    Bremer, Sara
    TRANSPLANT INTERNATIONAL, 2013, 26 : 252 - 252
12345